<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.2 20190208//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.2?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Biomol Struct Dyn</journal-id><journal-id journal-id-type="iso-abbrev">J Biomol Struct Dyn</journal-id><journal-title-group><journal-title>Journal of Biomolecular Structure &#x00026; Dynamics</journal-title></journal-title-group><issn pub-type="ppub">0739-1102</issn><issn pub-type="epub">1538-0254</issn><publisher><publisher-name>Taylor &#x00026; Francis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7594188</article-id><article-id pub-id-type="doi">10.1080/07391102.2020.1834457</article-id><article-id pub-id-type="publisher-id">1834457</article-id><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" vocab-term="Version of Record" article-version-type="VoR">Version of Record</article-version><article-categories><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Structural basis for the inhibition of SARS-CoV2 main protease by Indian medicinal plant-derived antiviral compounds</article-title><alt-title alt-title-type="left-running-head">K. M. Saravanan et al.</alt-title><alt-title alt-title-type="right-running-head">Journal of Biomolecular Structure and Dynamics</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5541-234X</contrib-id><name><surname>Saravanan</surname><given-names>Konda Mani</given-names></name><xref ref-type="aff" rid="AF0001">a</xref><xref ref-type="author-notes" rid="AUFN1">#</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Haiping</given-names></name><xref ref-type="aff" rid="AF0001">a</xref><xref ref-type="author-notes" rid="AUFN1">#</xref></contrib><contrib contrib-type="author"><name><surname>Senthil</surname><given-names>Renganathan</given-names></name><xref ref-type="aff" rid="AF0002">b</xref></contrib><contrib contrib-type="author"><name><surname>Vijayakumar</surname><given-names>Kevin Kumar</given-names></name><xref ref-type="aff" rid="AF0003">c</xref></contrib><contrib contrib-type="author"><name><surname>Sounderrajan</surname><given-names>Vignesh</given-names></name><xref ref-type="aff" rid="AF0004">d</xref></contrib><contrib contrib-type="author"><name><surname>Wei</surname><given-names>Yanjie</given-names></name><xref ref-type="aff" rid="AF0001">a</xref><xref ref-type="corresp" rid="AN0001"/></contrib><contrib contrib-type="author"><name><surname>Shakila</surname><given-names>Harshavardhan</given-names></name><xref ref-type="aff" rid="AF0003">c</xref><xref ref-type="corresp" rid="AN0001"/></contrib><aff id="AF0001"><label>a</label><institution>Center for High Performance Computing, Joint Engineering Research Center for Health Big Data Intelligent Analysis Technology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences</institution>, <city>Shenzhen</city>, <state>Guangdong</state>, <country>PR China</country></aff><aff id="AF0002"><label>b</label><institution>Department of Bioinformatics, Marudupandiyar College &#x00026; Lysine Biotech Pvt Ltd</institution>, <city>Thanjavur</city>, <state>Tamilnadu</state>, <country>India</country></aff><aff id="AF0003"><label>c</label><institution>Department of Molecular Microbiology, School of Biotechnology, Madurai Kamaraj University</institution>, <city>Madurai</city>, <state>Tamilnadu</state>, <country>India</country></aff><aff id="AF0004"><label>d</label><institution>Department of Zoology, GTN Arts college</institution>, <city>Dindigul</city>, <state>Tamilnadu</state>, <country>India</country></aff></contrib-group><author-notes><fn id="AUFN1"><label>#</label><p>Konda Mani Saravanana and Haiping Zhang are equal first authors.</p></fn><corresp id="AN0001">CONTACT Yanjie Wei <email>yj.wei@siat.ac.cn</email><institution>Center for High Performance Computing, Joint Engineering Research Center for Health Big Data Intelligent Analysis Technology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences</institution>, <city>Shenzhen</city>, <state>Guangdong</state><postal-code>518 055</postal-code>, <country>PR China</country>; Harshavardhan Shakila <email>mohanshakila@yahoo.com</email><institution>Department of Molecular Microbiology, School of Biotechnology, Madurai Kamaraj University</institution>, <city>Madurai</city>, <state>Tamilnadu</state><postal-code>625021</postal-code>, <country>India</country></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>19</day><month>10</month><year>2020</year></pub-date><pub-date date-type="collection" publication-format="electronic"><year>2020</year></pub-date><fpage seq="1">1</fpage><lpage>9</lpage><permissions><copyright-statement>&#x000a9; 2020 Informa UK Limited, trading as Taylor &#x00026; Francis Group</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Informa UK Limited, trading as Taylor &#x00026; Francis Group</copyright-holder><license><license-p>This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="TBSD_0_1834457.pdf"/><abstract><title>Abstract</title><p>A novel coronavirus (SARS-CoV2) has caused a major outbreak in humans around the globe, and it became a severe threat to human healthcare than all other infectious diseases. Researchers were urged to discover and test various approaches to control and prevent such a deadly disease. Considering the emergency and necessity, we screened reported antiviral compounds present in the traditional Indian medicinal plants for the inhibition of SARS-CoV2 main protease. In this study, we used molecular docking to screen 41 reported antiviral compounds that exist in Indian medicinal plants and shown amentoflavone from the plant <italic>Torreyanucifera</italic> with a higher docking score. Furthermore, we performed a 40&#x02009;ns atomic molecular dynamics simulation and free binding energy calculations to explore the stability of the top five protein&#x02013;ligand complexes. Through the article, we insist that the amentoflavone, hypericin and Torvoside H from the traditional Indian medicinal plants may be used as a potential inhibitor of SARS-CoV2 main protease and further biochemical experiments could shed light on understanding the mechanism of inhibition by these plant-derived antiviral compounds.</p><p>Communicated by Ramaswamy H. Sarma</p></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>SARS-CoV2</kwd><kwd>main protease</kwd><kwd>medicinal plants</kwd><kwd>molecular docking and dynamics</kwd><kwd>drug design</kwd></kwd-group><counts><fig-count count="4"/><table-count count="1"/><page-count count="9"/><word-count count="5743"/></counts></article-meta></front><body><sec sec-type="intro" id="S0001" disp-level="1"><title>Introduction</title><p>Infectious diseases caused by pathogens like parasites, fungi, bacteria or virus are one among the leading causes of mortality around the world. The recent outbreak of coronavirus disease (COVID-19) has shown the devastative effect on the humanity globally (World Health Organization, <xref rid="CIT0041" ref-type="bibr">2020</xref>). Currently, according to WHO the total COVID-19 confirmed cases have reached approximately 26.9 million and more than 880 thousand infected people died globally. Even though some countries are panning out this pandemic, several are still struggling to control the virus spreading. The first novel coronavirus (SARS-CoV2) was identified and reported in Wuhan city, China, at the end of December 2019 and on 30 January 2020 WHO declared a public health emergency of international concern (PHEIC) regarding the COVID-19 outbreak (Ji et&#x000a0;al., <xref rid="CIT0017" ref-type="bibr">2020</xref>; Lee &#x00026; Hsueh, <xref rid="CIT0024" ref-type="bibr">2020</xref>; Malik et&#x000a0;al., <xref rid="CIT0028" ref-type="bibr">2020</xref>; Xu et&#x000a0;al., <xref rid="CIT0042" ref-type="bibr">2020</xref>).</p><p>Human coronaviruses are predominantly concomitant with upper respiratory tract illnesses ranging from mild to moderate including common cold. Most of the people may be infected with one or more of these viruses at some point in their lifetime (Killerby et&#x000a0;al., <xref rid="CIT0020" ref-type="bibr">2018</xref>). The SARS-CoV and MERS-CoV are the two major causes of severe pneumonia in humans (Song et&#x000a0;al., <xref rid="CIT0035" ref-type="bibr">2019</xref>). The COVID-19 is known to show symptoms slowly over an incubation period of around 2&#x02009;weeks. The virus replicates in the upper and lower respiratory tract, forming lesions (Chan, Yuan, et&#x000a0;al., <xref rid="CIT0008" ref-type="bibr">2020</xref>). The general symptoms observed in the infected individuals are fever, cough, dyspnoea and lesion in the lungs (Huang et&#x000a0;al., <xref rid="CIT0015" ref-type="bibr">2020</xref>). In the advanced stage, the symptoms of this virus show pneumonia which progresses to severe pneumonia and acute respiratory distress syndrome (ARDS) which results in the need for life-support to sustain the patient's life (Lai et&#x000a0;al., <xref rid="CIT0023" ref-type="bibr">2020</xref>).</p><p>It has been reported that the SARS-CoV and SARS-CoV2 have similar kind of receptors, especially the receptor-binding domain (RBD) and the receptor-binding motif (RBM) in the viral genome (Tai et&#x000a0;al., <xref rid="CIT0038" ref-type="bibr">2020</xref>; Yin &#x00026; Wunderink, <xref rid="CIT0043" ref-type="bibr">2018</xref>; T. Zhang et&#x000a0;al., <xref rid="CIT0044" ref-type="bibr">2020</xref>). During the SARS infection, the RBM of the S protein gets directly attached to the Angiotension-Converting Enzyme 2 (ACE2) in the human or the host cells (Nikhat &#x00026; Fazil, <xref rid="CIT0033" ref-type="bibr">2020</xref>). The ACE2 protein is expressed in various organs of the human body mainly in the lungs, kidney and intestine, the prime targets of the coronavirus (Zhao et&#x000a0;al., <xref rid="CIT0047" ref-type="bibr">2020</xref>). SARS-CoV-2 shares homology with the SARS-CoV (70% of genes), but the rate of transmission and infectivity of the SARS-CoV2 has been remarkable; this accelerated spreading rate may be due to a gain of function mutation, making this novel virus different from the SARS-CoV virus.</p><p>Several therapeutic strategies have been tested throughout the world to mitigate the infection, however, at least for now it is limited to prevention of the infection and further complications such as multi-organ failure through supportive therapies. Few preliminary studies have explored the therapeutic potential of opinavir/ritonavir: a protease inhibitor commonly used in HIV treatment and others have reported the use of remdesivir: a nucleoside analogue, nucleoside reverse transcriptase inhibitor (NRTI) such as lamivudine and tenofovir disoproxilfumarate, and neuraminidase inhibitors (NAIs) such as peramivir, zanamivir and oseltamivirfor treating COVID-19. Recently, FDA approved remdesivir to be used as an emergency drug for treating acute COVID-19 cases (Blanco et&#x000a0;al., <xref rid="CIT0005" ref-type="bibr">2020</xref>; Chang et&#x000a0;al., <xref rid="CIT0009" ref-type="bibr">2020</xref>; Gordon et&#x000a0;al., <xref rid="CIT0014" ref-type="bibr">2020</xref>; Liao et&#x000a0;al., <xref rid="CIT0027" ref-type="bibr">2020</xref>). SARS-CoV2 is genetically similar to SARS-CoV sharing around 70% of genes. Chymotrypsin-like protease (3CL<sup>pro</sup>)/main protease (M<sup>pro</sup>) is an essential component for the replication of coronavirus and it is a potential target for designing anti-viral drugs against SARS-CoV2 (Anand et&#x000a0;al., <xref rid="CIT0002" ref-type="bibr">2003</xref>).</p><p>Traditional Indian medicine use plants, minerals and animal products for curing human diseases. Traditional knowledge regarding the plant sources and their usage are essential to use them accurately and for the right condition (<xref rid="CIT0037" ref-type="bibr">Tabuti et&#x000a0;al., 2003</xref>). About 25,000 plant-based formulations have been used in folk remedies in Indian medicine (Adhikari &#x00026; Paul, <xref rid="CIT0001" ref-type="bibr">2018</xref>). Owing to their use in traditional medicine, many plant molecules have been studied and subsequently modulated into drugs for various diseases (Bharadwaj et&#x000a0;al., <xref rid="CIT0004" ref-type="bibr">2019</xref>; Dwivedi et&#x000a0;al., <xref rid="CIT0012" ref-type="bibr">2020</xref>; Fabricant &#x00026; Farnsworth, <xref rid="CIT0013" ref-type="bibr">2001</xref>; Li-Weber, <xref rid="CIT0025" ref-type="bibr">2009</xref>).</p><p>Plant-derived compounds such as phytochemicals possess immense therapeutic potential with a wide range of bioactivities including anti-microbial, anti-fungal, anti-viral, anti-inflammatory, and anti-cancer properties. The SARS-CoV2 main protease is considered as a promising drug target in this study, since it is dissimilar to human proteases and its crucial role in the viral replication cycle (Ullrich &#x00026; Nitsche, <xref rid="CIT0039" ref-type="bibr">2020</xref>). With the knowledge gained on the structure and inhibitors of the main protease from previous epidemical coronaviruses, we strongly believe the main protease as one of the most attractive viral targets for antiviral drug discovery against SARS-CoV2. Hence, in the present study, we investigated potential anti-viral candidates found in Indian medicinal plants that may inhibit SARS-CoV2 main protease using molecular docking and molecular dynamics simulation approaches.</p></sec><sec sec-type="materials" id="S0002" disp-level="1"><title>Material and methods</title><sec id="S0002-S2001" disp-level="2"><title>Protein preparation</title><p>The three-dimensional structure of SARS-CoV2 main protease was considered as a major therapeutic target for COVID-19 (Jin et&#x000a0;al., <xref rid="CIT0018" ref-type="bibr">2020</xref>; Muralidharan et&#x000a0;al., <xref rid="CIT0032" ref-type="bibr">2020</xref>; H. Zhang et&#x000a0;al., <xref rid="CIT0044" ref-type="bibr">2020</xref>) and obtained from the Protein Data Bank (PDB-6Y2G) (Berman et&#x000a0;al., <xref rid="CIT0003" ref-type="bibr">2000</xref>; L. Zhang et&#x000a0;al., <xref rid="CIT0045" ref-type="bibr">2020</xref>). The protein chain is made up of 306 amino acid residues and experimentally solved by the X-ray diffraction method at 2.20&#x0212b; resolution. Protein structure retrieved was minimized by adding missing residues and hydrogen bonds by Autodock tools (Morris, Ruth, et&#x000a0;al., 2009). Active site identification remains a challenging task because of the presence of numerous cavities or pockets in a protein. In this case, the native cocrystallized ligand is used as a control for molecular docking experiments. To make a comparative study of the binding mode of main protease&#x02013;ligand complexes, initially we performed the docking studies with the known binder ((&#x0223c;{tert}-butyl &#x0223c;{N}-[1-[(2&#x02009;&#x0223c;&#x02009;{S})-3-cyclopropyl-1-oxidanylidene-1-[[(2&#x02009;&#x0223c;&#x02009;{S},3&#x02009;&#x0223c;&#x02009;{R})-3-oxidanyl-4-oxidanylidene-1-[(3&#x02009;&#x0223c;&#x02009;{S})-2-oxidanylidenepyrrolidin-3-yl]&#x02009;&#x02212;&#x02009;4- [(phenylmethyl)amino]butan-2-yl]amino]propan-2-yl]-2-oxidanylidene-pyridin-3-yl]carbamate) (co-crystallized) with docking score &#x02212;7.60 using autodock.</p></sec><sec id="S0002-S2002" disp-level="2"><title>Ligand preparation</title><p>Plant-based antiviral compounds were manually identified from the literature carefully and retrieved their structure from PubChem database (Kim et&#x000a0;al., <xref rid="CIT0021" ref-type="bibr">2019</xref>). Subsequently, all the compounds were converted to three-dimensional coordinates by using open babel molecular converter program and saved in PDB format (O&#x02019;Boyle et&#x000a0;al., <xref rid="CIT0034" ref-type="bibr">2011</xref>). Particularly, the native ligand and heteroatoms were removed from the receptor before docking, the compounds were optimized by adjusting rotamers preferences and energy minimization. The list of 41 antiviral compounds from Indian medicinal plants is shown in <xref rid="t0001" ref-type="table">Table 1</xref>.</p><table-wrap id="t0001" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Predicted binding energy of plants derived antiviral compounds with SARS-CoV2 main protease.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th align="left">S. No</th><th align="center">Compound name</th><th align="center">Plant name</th><th align="center">Family</th><th align="center">Binding energy (kcal/mol)</th></tr></thead><tbody valign="top"><tr><td align="left">1</td><td align="left">Amentoflavone</td><td align="left"><italic toggle="yes">Torreyanucifera</italic></td><td align="left"><italic toggle="yes">Taxaceae</italic></td><td align="char" char=".">&#x02212;10.0</td></tr><tr><td align="left">2</td><td align="left">Lectin</td><td align="left"><italic toggle="yes">Momordiacharantia</italic></td><td align="left"><italic toggle="yes">Cucurbitaceae</italic></td><td align="char" char=".">&#x02212;8.5</td></tr><tr><td align="left">3</td><td align="left">glycyrrhizicacid</td><td align="left"><italic toggle="yes">Glycyrrhizaglabra</italic></td><td align="left"><italic toggle="yes">Fabaceae</italic></td><td align="char" char=".">&#x02212;8.5</td></tr><tr><td align="left">4</td><td align="left">Hypericin</td><td align="left"><italic toggle="yes">Hypericumperforatum</italic></td><td align="left"><italic toggle="yes">Hypericaceae</italic></td><td align="char" char=".">&#x02212;8.4</td></tr><tr><td align="left">5</td><td align="left">Torvoside H</td><td align="left"><italic toggle="yes">Solanum torvum</italic></td><td align="left"><italic toggle="yes">Solanaceae</italic></td><td align="char" char=".">&#x02212;8.4</td></tr><tr><td align="left">6</td><td align="left">Galloylglucose 1</td><td align="left"><italic toggle="yes">Terminalia chebula</italic></td><td align="left"><italic toggle="yes">Combretaceae</italic></td><td align="char" char=".">&#x02212;8.3</td></tr><tr><td align="left">7</td><td align="left">Ocotillone</td><td align="left"><italic toggle="yes">Ailanthus allisima</italic></td><td align="left"><italic toggle="yes">Simaroubaceae</italic></td><td align="char" char=".">&#x02212;8.0</td></tr><tr><td align="left">8</td><td align="left">Saikosaponin B2</td><td align="left"><italic toggle="yes">Bupleurum sp.</italic></td><td align="left"><italic toggle="yes">Apiaceae</italic></td><td align="char" char=".">&#x02212;8.0</td></tr><tr><td align="left">9</td><td align="left">Berberine</td><td align="left"><italic toggle="yes">Berberisaristata</italic></td><td align="left"><italic toggle="yes">Berberidaceae</italic></td><td align="char" char=".">&#x02212;7.9</td></tr><tr><td align="left">10</td><td align="left">Camelliatannin H</td><td align="left"><italic toggle="yes">Camellia japonica</italic></td><td align="left"><italic toggle="yes">Theaceae</italic></td><td align="char" char=".">&#x02212;7.7</td></tr><tr><td align="left">11</td><td align="left">Bryophyllin A</td><td align="left"><italic toggle="yes">Kalanchoepinnata</italic></td><td align="left"><italic toggle="yes">Crassulaceae</italic></td><td align="char" char=".">&#x02212;7.6</td></tr><tr><td align="left">12</td><td align="left">lupeol</td><td align="left"><italic toggle="yes">Strobilanthuscusia</italic></td><td align="left"><italic toggle="yes">Acanthaceae</italic></td><td align="char" char=".">&#x02212;7.6</td></tr><tr><td align="left">13</td><td align="left">Quercetin</td><td align="left"><italic toggle="yes">Polygonumviscosum</italic></td><td align="left"><italic toggle="yes">Polygonaceae</italic></td><td align="char" char=".">&#x02212;7.6</td></tr><tr><td align="left">14</td><td align="left">Silymarin</td><td align="left"><italic toggle="yes">Silybummarianum</italic></td><td align="left">Asteraceae</td><td align="char" char=".">&#x02212;7.6</td></tr><tr><td align="left">15</td><td align="left">Myricetin</td><td align="left"><italic toggle="yes">Cochlospermum religiosum</italic></td><td align="left"><italic toggle="yes">Bixaceae</italic></td><td align="char" char=".">&#x02212;7.5</td></tr><tr><td align="left">16</td><td align="left">Torvanol A</td><td align="left"><italic toggle="yes">Solanum torvum</italic></td><td align="left"><italic toggle="yes">Solanaceae</italic></td><td align="char" char=".">&#x02212;7.5</td></tr><tr><td align="left">17</td><td align="left">Mimusopicacid</td><td align="left"><italic toggle="yes">Mimusopselengli</italic></td><td align="left"><italic toggle="yes">Sapotaceae</italic></td><td align="char" char=".">&#x02212;7.4</td></tr><tr><td align="left">18</td><td align="left">Scopadulcic_acid</td><td align="left"><italic toggle="yes">Scopariadulcis</italic></td><td align="left"><italic toggle="yes">Scrophulariaceae</italic></td><td align="char" char=".">&#x02212;7.4</td></tr><tr><td align="left">19</td><td align="left">Scutellarein</td><td align="left"><italic toggle="yes">&#x000a0;Oroxylum indicum</italic></td><td align="left"><italic toggle="yes">&#x000a0;Bignoniaceae</italic></td><td align="char" char=".">&#x02212;7.4</td></tr><tr><td align="left">20</td><td align="left">Daphnoretin</td><td align="left"><italic toggle="yes">Wickstroemiaindica</italic></td><td align="left"><italic toggle="yes">Thymelaceae</italic></td><td align="char" char=".">&#x02212;7.3</td></tr><tr><td align="left">21</td><td align="left">Apigenin</td><td align="left"><italic toggle="yes">Ranunculus scleratus</italic></td><td align="left"><italic toggle="yes">Ranunculaceae</italic></td><td align="char" char=".">&#x02212;7.1</td></tr><tr><td align="left">22</td><td align="left">Iridoid</td><td align="left"><italic toggle="yes">Barleriaprionitis</italic></td><td align="left"><italic toggle="yes">Acanthaceae</italic></td><td align="char" char=".">&#x02212;7.1</td></tr><tr><td align="left">23</td><td align="left">catechin</td><td align="left"><italic toggle="yes">Ephedra sinica</italic></td><td align="left"><italic toggle="yes">Ephedraceae</italic></td><td align="char" char=".">&#x02212;7.1</td></tr><tr><td align="left">24</td><td align="left">lycorine</td><td align="left"><italic toggle="yes">Hymenocallis littoralis</italic></td><td align="left"><italic toggle="yes">Amarylidaceae</italic></td><td align="char" char=".">&#x02212;7.0</td></tr><tr><td align="left">25</td><td align="left">Periglaucine</td><td align="left"><italic toggle="yes">Pericampylusglaucus</italic></td><td align="left"><italic toggle="yes">Menispermaceae</italic></td><td align="char" char=".">&#x02212;6.9</td></tr><tr><td align="left">26</td><td align="left">andrographolide</td><td align="left"><italic toggle="yes">Andrographispaniculata</italic></td><td align="left"><italic toggle="yes">Acanthaceae</italic></td><td align="char" char=".">&#x02212;6.9</td></tr><tr><td align="left">27</td><td align="left">Cepharadione B</td><td align="left"><italic toggle="yes">Piper betel</italic></td><td align="left"><italic toggle="yes">Piperaceae</italic>&#x000a0;&#x000a0;</td><td align="char" char=".">&#x02212;6.8</td></tr><tr><td align="left">28</td><td align="left">Ovatodiolide</td><td align="left"><italic toggle="yes">Anisomelesindica</italic></td><td align="left"><italic toggle="yes">Lamiaceae</italic></td><td align="char" char=".">&#x02212;6.8</td></tr><tr><td align="left">29</td><td align="left">Paederoside</td><td align="left"><italic toggle="yes">Paedariascandens</italic></td><td align="left"><italic toggle="yes">Rubiaceae</italic></td><td align="char" char=".">&#x02212;6.8</td></tr><tr><td align="left">30</td><td align="left">Catalpol</td><td align="left"><italic toggle="yes">Picrorhizakurroa</italic></td><td align="left"><italic toggle="yes">Scrophulariaceae</italic></td><td align="char" char=".">&#x02212;6.8</td></tr><tr><td align="left">31</td><td align="left">Coclaurine</td><td align="left"><italic toggle="yes">Nelumbonucifera</italic></td><td align="left"><italic toggle="yes">Nymphaceae</italic></td><td align="char" char=".">&#x02212;6.6</td></tr><tr><td align="left">32</td><td align="left">Curcumin</td><td align="left"><italic toggle="yes">Curcuma longa</italic></td><td align="left"><italic toggle="yes">Zingiberaceae</italic></td><td align="char" char=".">&#x02212;6.5</td></tr><tr><td align="left">33</td><td align="left">Nuciferine</td><td align="left"><italic toggle="yes">Nelumbonucifera</italic></td><td align="left"><italic toggle="yes">Nymphaceae</italic></td><td align="char" char=".">&#x02212;6.4</td></tr><tr><td align="left">34</td><td align="left">Rhuscholide A</td><td align="left"><italic toggle="yes">Rhussinensis</italic></td><td align="left"><italic toggle="yes">Anacardiaceae</italic></td><td align="char" char=".">&#x02212;6.3</td></tr><tr><td align="left">35</td><td align="left">Odorinol</td><td align="left"><italic toggle="yes">Aglaia roxburghiana</italic></td><td align="left"><italic toggle="yes">Meliaceae</italic></td><td align="char" char=".">&#x02212;6.3</td></tr><tr><td align="left">36</td><td align="left">Parthenolide</td><td align="left"><italic toggle="yes">Taracetium vulgare</italic></td><td align="left"><italic toggle="yes">Asteraceae</italic></td><td align="char" char=".">&#x02212;6.0</td></tr><tr><td align="left">37</td><td align="left">Furomollugin</td><td align="left"><italic toggle="yes">Rubiacardifolia</italic></td><td align="left"><italic toggle="yes">Rubiaceae</italic></td><td align="char" char=".">&#x02212;5.9</td></tr><tr><td align="left">38</td><td align="left">Illicinone-A</td><td align="left"><italic toggle="yes">Illiciumverum</italic></td><td align="left"><italic toggle="yes">Illiaceae</italic></td><td align="char" char=".">&#x02212;5.0</td></tr><tr><td align="left">39</td><td align="left">Naphthoquinone</td><td align="left"><italic toggle="yes">Rubiacardifolia</italic></td><td align="left"><italic toggle="yes">Rubiaceae</italic></td><td align="char" char=".">&#x02212;4.9</td></tr><tr><td align="left">40</td><td align="left">Piperitenone</td><td align="left"><italic toggle="yes">Lippiajavanica</italic></td><td align="left"><italic toggle="yes">Verbenaceae</italic></td><td align="char" char=".">&#x02212;4.3</td></tr><tr><td align="left">41</td><td align="left">Trypsin</td><td align="left"><italic toggle="yes">Milletia pinnata</italic></td><td align="left"><italic toggle="yes">Fabaceae</italic></td><td align="char" char=".">&#x02212;3.0</td></tr></tbody></table><table-wrap-foot><fn id="TF1"><p>Among the small molecules, amentoflavone found to show stand as the topmost based on the energy value.</p></fn></table-wrap-foot></table-wrap></sec><sec id="S0002-S2003" disp-level="2"><title>Molecular docking of antiviral compounds from Indian medicinal plants</title><p>Molecular docking was carried out to predict the affinity between the plants derived antiviral compounds against the main protease of SARS-CoV2 using Auto Dock 4.2 program (Morris, Goodsell, et&#x000a0;al., <xref rid="CIT0030" ref-type="bibr">2009</xref>). Polar hydrogen atoms were individually added and merged to the protein structure. Kollman charges and solvation parameters were determined by default. Gasteiger charges were added to the minimized ligand structures, and all bonds were made rotatable and flexible by allowing the detection of root torsion. Grid maps with grid spacing of 0.375&#x02009;&#x000c5; in the <italic>x</italic>, <italic>y</italic> and <italic>z</italic>-dimensions of 64&#x02009;&#x000d7;&#x02009;66&#x02009;&#x000d7;&#x02009;66 points were set to cover the entire protein. The Lamarckian Genetic Algorithm (LGA) was used to search for the lowest binding energy by implementing local minimization of the genetic algorithm, to enable modification of the gene population. LGA parameters were set as follows: 100 search (docking) runs; population size of 150; 25,000,000 of energy evaluations; 27,000 numbers of generations; a mutation rate of 0.02 and crossover rate of 0.8. Docking calculation was performed in the Auto Dock 4.2 software.</p></sec><sec id="S0002-S2004" disp-level="2"><title>Molecular dynamics simulation of top-scoring main protease&#x02013;amentoflavone complex</title><p>GROMACS 4.6 software was used to perform atomic molecular dynamics simulations with an all atom AMBER99SB force field (Case et&#x000a0;al., <xref rid="CIT0006" ref-type="bibr">2005</xref>) for the top five protein&#x02013;ligand complexes sorted based on docking scores. ACPYPE, which depends on Antechamber was used to generate ligand structural topology (Sousa Da Silva &#x00026; Vranken, <xref rid="CIT0036" ref-type="bibr">2012</xref>). The protein&#x02013;ligand complex system was solvated in a cubic box (size determined by keeping the closest protein atom to the box boundary at 1&#x02009;nm) of TIP3P (transferable intermolecular potential with 3 points) water (Jorgensen et&#x000a0;al., <xref rid="CIT0019" ref-type="bibr">1983</xref>) using minimization of the steepest descent algorithm. The net charge of the system was neutralized by adding counter ions. Charge interactions (electrostatic) were computed by the Particle Mesh Ewald method (Darden et&#x000a0;al., <xref rid="CIT0010" ref-type="bibr">1993</xref>). After refining the complex by energy minimization, a 1-ns isothermal-isovolumetric ensemble simulation was carried out to equilibrate the water box with a force constant of 1000&#x02009;kJ/(mol&#x000b7;&#x000c5;) in <italic>x</italic>, <italic>y</italic> and <italic>z</italic> dimensions. A 1-ns NpT (isobaric-isothermic) ensemble simulation was used to equilibrate the water box in 1&#x02009;atm pressure with a force constant of 1000&#x02009;kJ/(mol&#x000b7;&#x000c5;) in each dimension. Subsequently, another 40&#x02009;ns NpT ensemble MD simulation was performed for production simulation with a fixed temperature of 308&#x02009;K at 1&#x02009;atm pressure. Anisotropic diagonal position scaling on time step interval of 0.002&#x02009;ps was employed to maintain a constant pressure during MD simulations. Additionally, the Berendsen algorithm and Lennard-Jones cut-off value were fixed at 0.2 constant and 9&#x02009;&#x000c5;, respectively. Hydrogen bond formation was analyzed with Gromacs program modules. Analysis and plotting of results were carried out by using VMD and other standard inbuilt tools in Gromacs software (Humphrey et&#x000a0;al., <xref rid="CIT0016" ref-type="bibr">1996</xref>). The trajectory files are saved appropriately for further computations.</p></sec><sec id="S0002-S2005" disp-level="2"><title>Computation of binding free energy by MM-PBSA</title><p>The free binding energy of protein&#x02013;ligand complex structures was computed from Molecular dynamics trajectories by the Molecular Mechanics/Poisson-Boltzmann Surface Area (MMPBSA) approach (Wang et&#x000a0;al., <xref rid="CIT0040" ref-type="bibr">2018</xref>). The MM-PBSA free energy for all the top five protein&#x02013;ligand complexes was predicted. The last 20&#x02009;ns trajectory (20 frames from each nanosecond) of the 40&#x02009;ns normal NPT MD simulation was adopted to calculate the binding free energy by the MM/PBSA method in the g_mmpsba tool (Kumari et&#x000a0;al., <xref rid="CIT0022" ref-type="bibr">2014</xref>). The contribution of each residue toward the binding free energy was calculated and analyzed in detail.</p></sec></sec><sec sec-type="results" id="S0003" disp-level="1"><title>Results and discussion</title><p>Molecular docking plays a vibrant role in deciphering lead compounds identification. The ligand-binding sites identified from the crystal structure were selected as flexible residues for molecular docking studies. The docking of 41 plants based antiviral compounds against the main protease was carried out using Auto Dock 4.2. Protein and small molecules were given input by loading as macromolecule and ligands. In order to continue docking, hetero atoms were removed from the main protease structure and Kollman united atom charges, solvation parameters and polar hydrogens were added. Gasteiger charges and non-polar hydrogens were assigned to ligands. The grid was set by choosing residues in the identified pockets over main protease. Grid values set were &#x02212;10.764722, 12.509171 and 68.968991 for <italic>X</italic>, <italic>Y</italic> and <italic>Z</italic> axis, respectively. The Lamarckian genetic algorithm was preferred to examine the conformers in protein and maximum conformers were chosen as default poses for every compound during docking. Conformations (poses) of the protein&#x02013;ligand complex were observed from lowest to highest binding free energy (&#x00394;G) (<xref rid="t0001" ref-type="table">Table 1</xref>). From the result of docking, conformational similarity, intermolecular energy and RMSD were observed. The output was clustered based on the root-mean-square deviation (RMSD) tolerance of 2.0&#x02009;&#x000c5;.</p><p>The binding energy of 41 plant-derived antiviral compounds was shown in <xref rid="t0001" ref-type="table">Table 1</xref>. The compound amentoflavone from <italic>Torreyanucifera</italic> plant is shown to have the highest binding energy (&#x02212;10.0&#x02009;kcal/mol). Amentoflavone is a widely studied, naturally occurring polyphenolic biflavonoid found in many plants with wide bioactivities including anti-viral, anti-inflammatory, anti-cancer, anti-diabetic, anti-oxidant and anti-microbial properties (Chan, Yip, et&#x000a0;al., <xref rid="CIT0007" ref-type="bibr">2020</xref>; Li et&#x000a0;al., <xref rid="CIT0026" ref-type="bibr">2019</xref>). <italic>Selaginellabryopteris</italic> and <italic>Calophylluminophyllum</italic> are two other notable plants containing amentoflavone used in Indian traditional medicines. The top five compounds including amentoflavone such as lectin (<italic>Momordiacharantia)</italic>, glycyrrhizicacid (<italic>Glycyrrhizaglabra)</italic>, hypericin (<italic>Hypericumperforatum)</italic> and torvoside H (<italic>Solanum torvum</italic>) respectively are considered for further analysis.</p><p>The interactions like hydrogen, hydrophobic and other non-bonded terms between the top five compounds sorted by docking scores and main protease are visualized using Discovery Studio Visualizer software and was depicted in <xref ref-type="fig" rid="F0001">Figure 1</xref>. The interactions between protein and ligand are dominated by van der Waals hydrophobic interactions, which is indicated in light green color balls in the figure. The dark green color balls in the figure indicate conventional hydrogen bond contributions of amino acid residues. The red color ball in the figure indicates unfavorable hydrogen bonds. From the figure, it is observed that amentoflavone form the highest number of amino acid residue interactions (19 interactions) with the main protease than other four top compounds. The compounds lectin and hypericin form 16 amino acid residue interactions with main protease whereas other two compounds (glycyrrhizic acid and Torvoside H) form 18 and 17 amino acid residue interactions respectively. Interestingly, His41 contributes cation&#x02013;pi interaction and Cys44 contributes disulphide bridge formation to form strong and stable interactions.</p><fig id="F0001" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Schematic 3D and 2D interaction diagram of top five compounds with SARS-CoV2 main protease. Dark green balls indicate van der Waals interactions whereas light green color indicates hydrogen bonds. Yellow and red color indicates cation-pi and unfavorable hydrogen bonds between protein and ligand [Amentoflavone (A), Lectin (B), glycyrrhizicacid (C), Hypricin (D) and Torvoside H (E)].</p></caption><graphic content-type="color" xlink:href="TBSD_A_1834457_F0001_C"/></fig><p>The drug-likeness prediction of 41 Indian medicinal plants derived antiviral compounds were performed by using the program available at <ext-link ext-link-type="uri" xlink:href="http://www.scfbio-iitd.res.in/software/drugdesign/lipinski.jsp">http://www.scfbio-iitd.res.in/software/drugdesign/lipinski.jsp</ext-link> and tabulated in <xref rid="t0001" ref-type="table"><ext-link ext-link-type="uri" xlink:href="10.1080/07391102.2020.1834457">Supplementary Table 1</ext-link></xref>. For the top five compounds, an important Lipinski filter high lipophilicity (expressed as LogP less than 5) is satisfied. The molecular mass and hydrogen bond donors/acceptors of glycyrrhizicacid and Torvoside H are high compared to the other three compounds. Overall, the drug-likeness prediction results indicate the amentoflavone and hypericin as a likely drug.</p><sec id="S0003-S2001" disp-level="2"><title>Atomic molecular dynamics simulations of the main protease&#x02013;ligand complexes</title><p>Molecular dynamics simulations were carried out on the top five main protease&#x02013;ligand complexes (Amentoflavone, Lectin, glycyrrhizicacid, Hypricin and Torvoside H) obtained from the molecular docking program. The dynamic stability of the protein&#x02013;ligand complexes was estimated by observing RMSD changes during the simulation time as plotted in <xref ref-type="fig" rid="F0002">Figure 2</xref>. The fluctuation of protein complex structures was measured by balancing overall conformations during 40&#x02009;ns simulations. The root-mean-square deviation (RMSD) of the main protease&#x02013;amentoflavone complex along a 40-ns molecular dynamics simulation is highly stable which is evident from the average RMSD (&#x0003c;0.5&#x02009;nm). The RMSD of the other ligands is relatively dynamic compared to the protein RMSD (between 0.5 and 1&#x02009;nm), which is evident from the figure. In contrast, the RMSD of the main protease&#x02013;amentoflavone complex with a fitting reference indicates that the ligand itself undergoes a small degree of conformation change during binding. The backbone RMSD of the protein is acceptable for all the top five complexes and provides insights into the order of conformational changes.</p><fig id="F0002" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>The root mean square deviation of protein backbone and ligand (Amentoflavone (A), Lectin (B), glycyrrhizicacid (C), Hypricin (D) and Torvoside H (E)) for 40&#x02009;ns simulation time is presented.</p></caption><graphic content-type="color" xlink:href="TBSD_A_1834457_F0002_C"/></fig><p>Protein&#x02013;ligand interactions are typically stabilized by hydrogen, hydrophobic and electrostatic interactions. The formation of hydrogen bonds between protein and ligand for the 40&#x02009;ns simulation time is shown in <xref ref-type="fig" rid="F0003">Figure 3</xref>. An average of 6 and 4 hydrogen bonds are formed by amentoflavone and hypericin respectively with the main protease during the simulation which is high compared to the other three complexes. Interestingly, lectin forms very less number of hydrogen bonds with the main protease. The hydrogen bond number increased in the later stage of simulation indicating that enhanced hydrogen bonding is possible to form a stable protein&#x02013;ligand complex in the case of amentoflavone and hypericin complexes.</p><fig id="F0003" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>The number of hydrogen bonds formed between main protease-top five ligands (Amentoflavone (A), Lectin (B), glycyrrhizicacid (C), Hypericin (D) and Torvoside H (E)) for 40&#x02009;ns simulation time is presented.</p></caption><graphic content-type="color" xlink:href="TBSD_A_1834457_F0003_C"/></fig></sec><sec id="S0003-S2002" disp-level="2"><title>Binding free energy of protein&#x02013;ligand complexes</title><p>The computation of the binding free energy of protein and ligand complex by molecular mechanics&#x02014;Poisson-Boltzmann surface area continuum salvation (MM-PBSA) is the most commonly used methods to support the results of molecular docking. The physical property of protein and ligand complexes were calculated using the MM_PBSA approach. The binding energies were predicted through the MD trajectories. The snapshot of the last frame during free energy calculations was extracted and presented in <xref ref-type="fig" rid="F0004">Figure 4</xref>. The free binding energy of protein with hypericin (&#x02212;111.172&#x02009;kJ/mol) and amentoflavone (&#x02212;92.314&#x02009;kJ/mol) are higher than the other three protein&#x02013;ligand complexes which is presented in <xref ref-type="fig" rid="F0004">Figure 4</xref>. Interestingly, the main protease&#x02013;glycyrrhizicacid complex has very low free binding energy (&#x02212;20.903&#x02009;kJ/mol). Other stabilizing physical free energies such as van der Waals, electrostatic and Solvent Accessible Surface Area (SASA) were also presented in <xref ref-type="fig" rid="F0004">Figure 4</xref>. The main protease&#x02013;Torvoside H complex shows higher van der Waals (&#x02212;235.71&#x02009;kJ/mol), electrostatic (&#x02212;76.324&#x02009;kJ/mol) and SASA free energies (&#x02212;24.658&#x02009;kJ/mol). Through our observations, amentaflavone, hypericin and Torvoside H complexed with SARS-CoV2 main protease show better free energies predicted as evidenced from <xref ref-type="fig" rid="F0004">Figure 4</xref>. The importance and antiviral activity of the above three compounds is reviewed in the literature (Dhawan, <xref rid="CIT0011" ref-type="bibr">2012</xref>). The analysis of per residue-free energy of main protease suggests the importance of amino acid residues in ligand binding which is presented in <xref ref-type="fig" rid="F0001"><ext-link ext-link-type="uri" xlink:href="10.1080/07391102.2020.1834457">Supplementary Figure 1</ext-link></xref>. From the figure, it is observed that the hydrophobic residues (Leu141, Thr45 and Thr190), charged residues (Asn142 and Glu166) and Salt bridges (Cys44) forms stabilizing interactions between protein and ligands.</p><fig id="F0004" orientation="portrait" position="float"><label>Figure 4.</label><caption><p>The snapshots of last frame of top five complexes (Amentoflavone (A), Lectin (B), glycyrrhizicacid (C), Hypericin (D) and Torvoside H (E)) were presented. Free binding energy (kJ/mol) calculated using MMGBSA method for above top five protein&#x02013;ligand complexes after molecular docking simulation.</p></caption><graphic content-type="color" xlink:href="TBSD_A_1834457_F0004_C"/></fig></sec></sec><sec sec-type="conclusions" id="S0004" disp-level="1"><title>Conclusion</title><p>In conclusion, we screened 41 plant-derived compounds from Indian medicinal plants that may inhibit SARS-CoV2 main protease using the molecular docking approach. In our molecular docking study, we found amentoflavone, lectin, glycyrrhizicacid, hypericin and torvoside H showed high binding energy. However, among them, amentoflavone from <italic>Torreyanucifera</italic> plant showed highest binding energy of &#x02212;10.0&#x02009;kcal/mol with the SARS-COV2 main protease and further <italic>In vitro</italic> and <italic>In&#x000a0;Vivo</italic> studies are required to understand the underlying molecular mechanisms and signaling pathways involved in SARS-COV2 main protease inhibition. In the literature, there are reports based on insilico studies that the amentoflavone can act as a potential inhibitor of SARS-CoV2 (Mishra et&#x000a0;al., <xref rid="CIT0029" ref-type="bibr">2020</xref>). Furthermore, we performed molecular dynamics simulations and free energy calculations on the top five compounds to validate our findings from the molecular docking procedure. A careful analysis of results suggests that the compounds such as amentaflavone, hypericin, and Torvoside H respectively complexed with SARS-CoV2 main protease show better binding with stabilizing interactions. Our results provide detailed protein&#x02013;ligand interactions of five Indian medicinal plants derived antiviral compounds by a 40&#x02009;ns atomic molecular dynamics simulations. We believe our research would provide valuable information in developing new, novel and natural anti-viral drugs for COVID-19.</p></sec></body><back><ack><title>Acknowledgements</title><p>HS and KKV would like to acknowledge the DST FIST facility for this study.</p></ack><sec id="S0005" disp-level="1" sec-type="COI-statement"><title>Disclosure statement</title><p>No potential conflict of interest was reported by the authors.</p></sec><ref-list><title>References</title><ref id="CIT0001"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adhikari</surname><given-names>P. P.</given-names></name>, &#x00026; <name name-style="western"><surname>Paul</surname><given-names>S. B.</given-names></name></person-group> (<year>2018</year>). <article-title>History of Indian traditional medicine: A medical inheritance</article-title>. <source><italic toggle="yes">Asian Journal of Pharmaceutical and Clinical Research</italic></source>, (<issue>1</issue>), <fpage>421</fpage>
<pub-id pub-id-type="doi">10.22159/ajpcr.2018.v11i1.21893</pub-id></mixed-citation></ref><ref id="CIT0002"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anand</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Ziebuhr</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Wadhwani</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Mesters</surname><given-names>J. R.</given-names></name>, &#x00026; <name name-style="western"><surname>Hilgenfeld</surname><given-names>R.</given-names></name></person-group> (<year>2003</year>). <article-title>Coronavirus main proteinase (3CLpro) structure: Basis for design of anti-SARS drugs</article-title>. <source>Science (New Y<italic toggle="yes">ork</italic>, N.Y.<italic toggle="yes">)</italic></source>, (<issue>5626</issue>), <fpage>1763</fpage>&#x02013;<lpage>1767</lpage>. <pub-id pub-id-type="doi">10.1126/science.1085658</pub-id></mixed-citation></ref><ref id="CIT0003"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berman</surname><given-names>H. M.</given-names></name>, <name name-style="western"><surname>Westbrook</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Gilliland</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Bhat</surname><given-names>T. N.</given-names></name>, <name name-style="western"><surname>Weissig</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Shindyalov</surname><given-names>I. N.</given-names></name>, &#x00026; <name name-style="western"><surname>Bourne</surname><given-names>P. E.</given-names></name></person-group> (<year>2000</year>). <article-title>The protein data bank</article-title>. <source><italic toggle="yes">Nucleic Acids Research</italic></source>, (<issue>1</issue>), <fpage>235</fpage>&#x02013;<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1093/nar/28.1.235</pub-id><pub-id pub-id-type="pmid">10592235</pub-id></mixed-citation></ref><ref id="CIT0004"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bharadwaj</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>K. E.</given-names></name>, <name name-style="western"><surname>Dwivedi</surname><given-names>V. D.</given-names></name>, <name name-style="western"><surname>Yadava</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Panwar</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Lucas</surname><given-names>S. J.</given-names></name>, <name name-style="western"><surname>Pandey</surname><given-names>A.</given-names></name>, &#x00026; <name name-style="western"><surname>Kang</surname><given-names>S. G.</given-names></name></person-group> (<year>2019</year>). <article-title>Discovery of Ganoderma lucidum triterpenoids as potential inhibitors against Dengue virus NS2B-NS3 protease</article-title>. <source><italic toggle="yes">Scientific Reports</italic></source>, (<issue>1</issue>). <pub-id pub-id-type="doi">10.1038/s41598-019-55723-5</pub-id></mixed-citation></ref><ref id="CIT0005"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blanco</surname><given-names>J. L.</given-names></name>, <name name-style="western"><surname>Ambrosioni</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Garcia</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Mart&#x000ed;nez</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Soriano</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Mallolas</surname><given-names>J.</given-names></name>, &#x00026; <name name-style="western"><surname>Miro</surname><given-names>J. M.</given-names></name></person-group> (<year>2020</year>). <article-title>COVID-19 in patients with HIV: Clinical case series</article-title>. <source><italic toggle="yes">The Lancet HIV</italic></source>, (<issue>5</issue>), <fpage>e314</fpage>&#x02013;<lpage>e316</lpage>. <pub-id pub-id-type="doi">10.1016/S2352-3018(20)30111-9</pub-id><pub-id pub-id-type="pmid">32304642</pub-id></mixed-citation></ref><ref id="CIT0006"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Case</surname><given-names>D. A.</given-names></name>, <name name-style="western"><surname>Cheatham</surname><given-names>T. E.</given-names></name>, <name name-style="western"><surname>Darden</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Gohlke</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Merz</surname><given-names>K. M.</given-names></name>, <name name-style="western"><surname>Onufriev</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Simmerling</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>B.</given-names></name>, &#x00026; <name name-style="western"><surname>Woods</surname><given-names>R. J.</given-names></name></person-group> (<year>2005</year>). <article-title>The Amber biomolecular simulation programs</article-title>. <source><italic toggle="yes">Journal of Computational Chemistry</italic></source>, (<issue>16</issue>), <fpage>1668</fpage>&#x02013;<lpage>1688</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.20290</pub-id><pub-id pub-id-type="pmid">16200636</pub-id></mixed-citation></ref><ref id="CIT0007"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>J. F.-W.</given-names></name>, <name name-style="western"><surname>Yuan</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Kok</surname><given-names>K.-H.</given-names></name>, <name name-style="western"><surname>To</surname><given-names>K. K.-W.</given-names></name>, <name name-style="western"><surname>Chu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Xing</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Yip</surname><given-names>C. C.-Y.</given-names></name>, <name name-style="western"><surname>Poon</surname><given-names>R. W.-S.</given-names></name>, <name name-style="western"><surname>Tsoi</surname><given-names>H.-W.</given-names></name>, <name name-style="western"><surname>Lo</surname><given-names>S. K.-F.</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>K.-H.</given-names></name>, <name name-style="western"><surname>Poon</surname><given-names>V. K.-M.</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>W.-M.</given-names></name>, <name name-style="western"><surname>Ip</surname><given-names>J. D.</given-names></name>, <name name-style="western"><surname>Cai</surname><given-names>J.-P.</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>V. C.-C.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Hui</surname><given-names>C. K.-M.</given-names></name>, &#x00026; <name name-style="western"><surname>Yuen</surname><given-names>K.-Y.</given-names></name></person-group> (<year>2020</year>). <article-title>A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster</article-title>. <source><italic toggle="yes">The Lancet</italic></source>, (<issue>10223</issue>), <fpage>514</fpage>&#x02013;<lpage>523</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30154-9</pub-id></mixed-citation></ref><ref id="CIT0008"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>J. F. W.</given-names></name>, <name name-style="western"><surname>Yip</surname><given-names>C. C. Y.</given-names></name>, <name name-style="western"><surname>To</surname><given-names>K. K. W.</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>T. H. C.</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>S. C. Y.</given-names></name>, <name name-style="western"><surname>Leung</surname><given-names>K. H.</given-names></name>, <name name-style="western"><surname>Fung</surname><given-names>A. Y. F.</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>A. C. K.</given-names></name>, <name name-style="western"><surname>Zou</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Tsoi</surname><given-names>H. W.</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>G. K. Y.</given-names></name>, <name name-style="western"><surname>Tam</surname><given-names>A. R.</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>V. C. C.</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>K. H.</given-names></name>, <name name-style="western"><surname>Tsang</surname><given-names>O. T. Y.</given-names></name>, &#x00026; <name name-style="western"><surname>Yuen</surname><given-names>K. Y.</given-names></name></person-group> (<year>2020</year>). <article-title>Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated in&#x000a0;vitro and with clinical specimens</article-title>. <source><italic toggle="yes">Journal of Clinical Microbiology</italic></source>, (<issue>5</issue>), e00310-20. <pub-id pub-id-type="doi">10.1128/JCM.00310-20</pub-id></mixed-citation></ref><ref id="CIT0009"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Tung</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Hsiao</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Hsieh</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Su</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Tu</surname><given-names>Y. E.</given-names></name>, &#x00026; <name name-style="western"><surname>Tung</surname><given-names>C.</given-names></name></person-group> (<year>2020</year>). <article-title>Potential therapeutic agents for COVID-19 based on the analysis of protease and RNA polymerase docking</article-title>. <source><italic toggle="yes">Preprint</italic></source>. <pub-id pub-id-type="doi">10.20944/preprints202002.0242.v1</pub-id></mixed-citation></ref><ref id="CIT0010"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Darden</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>York</surname><given-names>D.</given-names></name>, &#x00026; <name name-style="western"><surname>Pedersen</surname><given-names>L.</given-names></name></person-group> (<year>1993</year>). <article-title>Particle mesh Ewald: An N&#x000b7;log(N) method for Ewald sums in large systems</article-title>. <source><italic toggle="yes">The Journal of Chemical Physics</italic></source>, (<issue>12</issue>), <fpage>10089</fpage>&#x02013;<lpage>10092</lpage>. <pub-id pub-id-type="doi">10.1063/1.464397</pub-id></mixed-citation></ref><ref id="CIT0011"><mixed-citation publication-type="confproc"><person-group person-group-type="author"><name name-style="western"><surname>Dhawan</surname><given-names>B. N.</given-names></name></person-group> (<year>2012</year>). <article-title>Anti-viral activity of Indian plants</article-title>. <source><italic toggle="yes">Proceedings of the National Academy of Sciences India Section B &#x02013; Biological Sciences, 82</italic></source>(1), 209&#x02013;224. <pub-id pub-id-type="doi">10.1007/s40011-011-0016-7</pub-id>.</mixed-citation></ref><ref id="CIT0012"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dwivedi</surname><given-names>V. D.</given-names></name>, <name name-style="western"><surname>Bharadwaj</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Afroz</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Khan</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Ansari</surname><given-names>M. A.</given-names></name>, <name name-style="western"><surname>Yadava</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Tripathi</surname><given-names>R. C.</given-names></name>, <name name-style="western"><surname>Tripathi</surname><given-names>I. P.</given-names></name>, <name name-style="western"><surname>Mishra</surname><given-names>S. K.</given-names></name>, &#x00026; <name name-style="western"><surname>Kang</surname><given-names>S. G.</given-names></name></person-group> (<year>2020</year>). <article-title>Anti-dengue infectivity evaluation of bioflavonoid from <italic>Azadirachta indica</italic> by dengue virus serine protease inhibition</article-title>. <source><italic toggle="yes">Journal of Biomolecular Structure and Dynamics</italic></source>. <pub-id pub-id-type="doi">10.1080/07391102.2020.1734485</pub-id></mixed-citation></ref><ref id="CIT0013"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fabricant</surname><given-names>D. S.</given-names></name>, &#x00026; <name name-style="western"><surname>Farnsworth</surname><given-names>N. R.</given-names></name></person-group> (<year>2001</year>). <article-title>The value of plants used in traditional medicine for drug discovery</article-title>. <source><italic toggle="yes">Environmental Health Perspectives</italic></source>, (<issue>Suppl 1</issue>), <fpage>69</fpage>&#x02013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1289/ehp.01109s169</pub-id><pub-id pub-id-type="pmid">11250806</pub-id></mixed-citation></ref><ref id="CIT0014"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gordon</surname><given-names>C. J.</given-names></name>, <name name-style="western"><surname>Tchesnokov</surname><given-names>E. P.</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>J. Y.</given-names></name>, <name name-style="western"><surname>Porter</surname><given-names>D. P.</given-names></name>, &#x00026; <name name-style="western"><surname>Gotte</surname><given-names>M.</given-names></name></person-group> (<year>2020</year>). <article-title>The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus</article-title>. <source>The <italic toggle="yes">Journal of Biological Chemistry</italic></source>, (<issue>15</issue>), <fpage>4773</fpage>&#x02013;<lpage>4779</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.AC120.013056</pub-id><pub-id pub-id-type="pmid">32094225</pub-id></mixed-citation></ref><ref id="CIT0015"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Fan</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Nie</surname><given-names>H. L.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>F. B.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Xia</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Zuo</surname><given-names>X.</given-names></name>, &#x00026; <name name-style="western"><surname>Huang</surname><given-names>J.</given-names></name></person-group> (<year>2020</year>). <article-title>COVID-19: A call for physical scientists and engineers</article-title>. <source><italic toggle="yes">ACS Nano</italic></source>, (<issue>4</issue>), <fpage>3747</fpage>&#x02013;<lpage>3754</lpage>. <pub-id pub-id-type="doi">10.1021/acsnano.0c02618</pub-id><pub-id pub-id-type="pmid">32267678</pub-id></mixed-citation></ref><ref id="CIT0016"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Humphrey</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Dalke</surname><given-names>A.</given-names></name>, &#x00026; <name name-style="western"><surname>Schulten</surname><given-names>K.</given-names></name></person-group> (<year>1996</year>). <article-title>VMD: Visual molecular dynamics</article-title>. <source><italic toggle="yes">Journal of Molecular Graphics</italic></source>, (<issue>1</issue>), <fpage>33</fpage>&#x02013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/0263-7855(96)00018-5</pub-id><pub-id pub-id-type="pmid">8744570</pub-id></mixed-citation></ref><ref id="CIT0017"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ji</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Zai</surname><given-names>J.</given-names></name>, &#x00026; <name name-style="western"><surname>Li</surname><given-names>X.</given-names></name></person-group> (<year>2020</year>). <article-title>Cross-species transmission of the newly identified coronavirus 2019-nCoV</article-title>. <source><italic toggle="yes">Journal of Medical Virology</italic></source>, (<issue>4</issue>), <fpage>433</fpage>&#x02013;<lpage>440</lpage>. <pub-id pub-id-type="doi">10.1002/jmv.25682</pub-id><pub-id pub-id-type="pmid">31967321</pub-id></mixed-citation></ref><ref id="CIT0018"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jin</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Du</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Duan</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Guddat</surname><given-names>L. W.</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>H.</given-names></name>, &#x00026; <name name-style="western"><surname>Rao</surname><given-names>Z.</given-names></name></person-group> (<year>2020</year>). <article-title>Structural basis for the inhibition of COVID-19 virus main protease by carmofur, an antineoplastic drug</article-title>. <source><italic toggle="yes">Nature Structural &#x00026; Molecular Biology</italic></source>, , <fpage>529</fpage>&#x02013;<lpage>532</lpage>. https//doi.org/10.1038/s41594-020-0440-6</mixed-citation></ref><ref id="CIT0019"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jorgensen</surname><given-names>W. L.</given-names></name>, <name name-style="western"><surname>Chandrasekhar</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Madura</surname><given-names>J. D.</given-names></name>, <name name-style="western"><surname>Impey</surname><given-names>R. W.</given-names></name>, &#x00026; <name name-style="western"><surname>Klein</surname><given-names>M. L.</given-names></name></person-group> (<year>1983</year>). <article-title>Comparison of simple potential functions for simulating liquid water</article-title>. <source><italic toggle="yes">The Journal of Chemical Physics</italic></source>, (<issue>2</issue>), <fpage>926</fpage>&#x02013;<lpage>935</lpage>. <pub-id pub-id-type="doi">10.1063/1.445869</pub-id></mixed-citation></ref><ref id="CIT0020"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Killerby</surname><given-names>M. E.</given-names></name>, <name name-style="western"><surname>Biggs</surname><given-names>H. M.</given-names></name>, <name name-style="western"><surname>Haynes</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Dahl</surname><given-names>R. M.</given-names></name>, <name name-style="western"><surname>Mustaquim</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Gerber</surname><given-names>S. I.</given-names></name>, &#x00026; <name name-style="western"><surname>Watson</surname><given-names>J. T.</given-names></name></person-group> (<year>2018</year>). <article-title>Human coronavirus circulation in the United States 2014&#x02013;2017</article-title>. <source><italic toggle="yes">Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology</italic></source>, , <fpage>52</fpage>&#x02013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcv.2018.01.019</pub-id></mixed-citation></ref><ref id="CIT0021"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Gindulyte</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>He</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>He</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Shoemaker</surname><given-names>B. A.</given-names></name>, <name name-style="western"><surname>Thiessen</surname><given-names>P. A.</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Zaslavsky</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name>, &#x00026; <name name-style="western"><surname>Bolton</surname><given-names>E. E.</given-names></name></person-group> (<year>2019</year>). <article-title>PubChem 2019 update: Improved access to chemical data</article-title>. <source><italic toggle="yes">Nucleic Acids Research</italic></source>, (<issue>D1</issue>), <fpage>D1102</fpage>&#x02013;<lpage>D1109</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky1033</pub-id><pub-id pub-id-type="pmid">30371825</pub-id></mixed-citation></ref><ref id="CIT0022"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumari</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Kumar</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Consortium</surname><given-names>O. S. D. D.</given-names></name>, &#x00026; <name name-style="western"><surname>Lynn</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="editor"><collab>Open Source Drug Discovery Consortium</collab></person-group> (<year>2014</year>). <article-title>g _ mmpbsa &#x02013; A GROMACS tool for MM-PBSA and its optimization for high-throughput binding energy calculations</article-title>. <source><italic toggle="yes">Journal of Chemical Information and Modeling</italic></source>, (<issue>7</issue>), <fpage>1951</fpage>&#x02013;<lpage>1962</lpage>. <pub-id pub-id-type="doi">10.1021/ci500020m</pub-id><pub-id pub-id-type="pmid">24850022</pub-id></mixed-citation></ref><ref id="CIT0023"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lai</surname><given-names>C. C.</given-names></name>, <name name-style="western"><surname>Shih</surname><given-names>T. P.</given-names></name>, <name name-style="western"><surname>Ko</surname><given-names>W. C.</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>H. J.</given-names></name>, &#x00026; <name name-style="western"><surname>Hsueh</surname><given-names>P. R.</given-names></name></person-group> (<year>2020</year>). <article-title>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges</article-title>. <source>International Journal <italic toggle="yes">of Antimicrobial Agents</italic></source>, (<issue>3</issue>), <fpage>105924</fpage>
<pub-id pub-id-type="doi">10.1016/j.ijantimicag.2020.105924</pub-id><pub-id pub-id-type="pmid">32081636</pub-id></mixed-citation></ref><ref id="CIT0024"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>P. I.</given-names></name>, &#x00026; <name name-style="western"><surname>Hsueh</surname><given-names>P. R.</given-names></name></person-group> (<year>2020</year>). <article-title>Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV</article-title>. <source><italic toggle="yes">Journal of Microbiology, Immunology and Infection</italic></source>, (<issue>3</issue>), <fpage>365</fpage>&#x02013;<lpage>367</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmii.2020.02.001</pub-id></mixed-citation></ref><ref id="CIT0025"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li-Weber</surname><given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>New therapeutic aspects of flavones: The anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin</article-title>. <source>Cancer Treatment Reviews</source>, (<issue>1</issue>), <fpage>57</fpage>&#x02013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1016/j.ctrv.2008.09.005</pub-id><pub-id pub-id-type="pmid">19004559</pub-id></mixed-citation></ref><ref id="CIT0026"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Su</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Jia</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Qing</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>K.</given-names></name>, &#x00026; <name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name></person-group> (<year>2019</year>). <article-title>Amentoflavone inhibits HSV-1 and ACV-resistant strain infection by suppressing viral early infection</article-title>. <source>Viruses</source>, (<issue>5</issue>), <fpage>466</fpage>
<pub-id pub-id-type="doi">10.3390/v11050466</pub-id></mixed-citation></ref><ref id="CIT0027"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liao</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Way</surname><given-names>G.</given-names></name>, &#x00026; <name name-style="western"><surname>Madahar</surname><given-names>V.</given-names></name></person-group> (<year>2020</year>). <article-title>Target virus or target ourselves for COVID-19 drugs discovery?-Lessons learned from anti-influenzas virus therapies</article-title>. <source><italic toggle="yes">World Journal of Virology</italic></source>, (<issue>3</issue>), <fpage>19</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1016/j.medidd.2020.100037</pub-id><pub-id pub-id-type="pmid">33024716</pub-id></mixed-citation></ref><ref id="CIT0028"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malik</surname><given-names>Y. S.</given-names></name>, <name name-style="western"><surname>Sircar</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Bhat</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Sharun</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Dhama</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Dadar</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Tiwari</surname><given-names>R.</given-names></name>, &#x00026; <name name-style="western"><surname>Chaicumpa</surname><given-names>W.</given-names></name></person-group> (<year>2020</year>). <article-title>Emerging novel coronavirus (2019-nCoV)&#x02014;Current scenario, evolutionary perspective based on genome analysis and recent developments</article-title>. <source>The <italic toggle="yes">Veterinary Quarterly</italic></source>, (<issue>1</issue>), <fpage>68</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1080/01652176.2020.1727993</pub-id><pub-id pub-id-type="pmid">32036774</pub-id></mixed-citation></ref><ref id="CIT0029"><mixed-citation publication-type="newspaper"><person-group person-group-type="author"><name name-style="western"><surname>Mishra</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Pathak</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Tripathi</surname><given-names>V.</given-names></name></person-group> (<year>2020</year>). Natural compounds as potential inhibitors of novel coronavirus (COVID-19) main protease: An in silico study.&#x000a0;<italic>Preprint</italic>
<pub-id pub-id-type="doi">10.21203/rs.3.rs-22839/v1</pub-id>.</mixed-citation></ref><ref id="CIT0030"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morris</surname><given-names>G. M.</given-names></name>, <name name-style="western"><surname>Ruth</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Lindstrom</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Sanner</surname><given-names>M. F.</given-names></name>, <name name-style="western"><surname>Belew</surname><given-names>R. K.</given-names></name>, <name name-style="western"><surname>Goodsell</surname><given-names>D. S.</given-names></name>, &#x00026; <name name-style="western"><surname>Olson</surname><given-names>A. J.</given-names></name></person-group> (<year>2009</year>). <article-title>Software news and updates AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility</article-title>. <source><italic toggle="yes">Journal of Computational Chemistry</italic></source>, (<issue>16</issue>), <fpage>2785</fpage>&#x02013;<lpage>2791</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.21256</pub-id><pub-id pub-id-type="pmid">19399780</pub-id></mixed-citation></ref><ref id="CIT0032"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muralidharan</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Sakthivel</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Velmurugan</surname><given-names>D.</given-names></name>, &#x00026; <name name-style="western"><surname>Gromiha</surname><given-names>M. M.</given-names></name></person-group> (<year>2020</year>). <article-title>Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19</article-title>. <source><italic toggle="yes">Journal of Biomolecular Structure and Dynamics</italic></source>, <pub-id pub-id-type="doi">10.1080/07391102.2020.1752802</pub-id></mixed-citation></ref><ref id="CIT0033"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nikhat</surname><given-names>S.</given-names></name>, &#x00026; <name name-style="western"><surname>Fazil</surname><given-names>M.</given-names></name></person-group> (<year>2020</year>). <article-title>Overview of Covid-19; its prevention and management in the light of Unani medicine</article-title>. <source>The <italic toggle="yes">Science of the Total Environment</italic></source>, , <fpage>138859</fpage>
<pub-id pub-id-type="doi">10.1016/j.scitotenv.2020.138859</pub-id><pub-id pub-id-type="pmid">32334163</pub-id></mixed-citation></ref><ref id="CIT0034"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#x02019;Boyle</surname><given-names>N. M.</given-names></name>, <name name-style="western"><surname>Banck</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>James</surname><given-names>C. A.</given-names></name>, <name name-style="western"><surname>Morley</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Vandermeersch</surname><given-names>T.</given-names></name>, &#x00026; <name name-style="western"><surname>Hutchison</surname><given-names>G. R.</given-names></name></person-group> (<year>2011</year>). <article-title>Open Babel: An open chemical toolbox</article-title>. <source><italic toggle="yes">Journal of Cheminformatics</italic></source>, <pub-id pub-id-type="doi">10.1186/1758-2946-3-33</pub-id></mixed-citation></ref><ref id="CIT0035"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Bao</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Qu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>Y.</given-names></name>, &#x00026; <name name-style="western"><surname>Qin</surname><given-names>C.</given-names></name></person-group> (<year>2019</year>). <article-title>From SARS to MERS, thrusting coronaviruses into the spotlight</article-title>. <source>Viruses</source>, (<issue>1</issue>), <fpage>59</fpage>
<pub-id pub-id-type="doi">10.3390/v11010059</pub-id></mixed-citation></ref><ref id="CIT0036"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sousa Da Silva</surname><given-names>A. W.</given-names></name>, &#x00026; <name name-style="western"><surname>Vranken</surname><given-names>W. F.</given-names></name></person-group> (<year>2012</year>). <article-title>ACPYPE &#x02013; AnteChamber PYthon Parser interfacE</article-title>. <source><italic toggle="yes">BMC Research Notes</italic></source>, (<issue>1</issue>), <fpage>367</fpage>
<pub-id pub-id-type="doi">10.1186/1756-0500-5-367</pub-id><pub-id pub-id-type="pmid">22824207</pub-id></mixed-citation></ref><ref id="CIT0037"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tabuti</surname><given-names>J. R. S.</given-names></name>, <name name-style="western"><surname>Lye</surname><given-names>K. A.</given-names></name>, &#x00026; <name name-style="western"><surname>Dhillion</surname><given-names>S. S.</given-names></name></person-group> (<year>2003</year>). <article-title>Traditional herbal drugs of Bulamogi, Uganda: Plants, use and administration</article-title>. <source><italic toggle="yes">Journal of Ethnopharmacology</italic></source>, (<issue>1</issue>), <fpage>19</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/S0378-8741(03)00161-2</pub-id></mixed-citation></ref><ref id="CIT0038"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tai</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>He</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Pu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Voronin</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>Y.</given-names></name>, &#x00026; <name name-style="western"><surname>Du</surname><given-names>L.</given-names></name></person-group> (<year>2020</year>). <article-title>Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: Implication for development of RBD protein as a viral attachment inhibitor and vaccine</article-title>. <source><italic toggle="yes">Cellular and Molecular Immunology</italic></source>, (<issue>6</issue>), <fpage>613</fpage>&#x02013;<lpage>620</lpage>. <pub-id pub-id-type="doi">10.1038/s41423-020-0400-4</pub-id>.<pub-id pub-id-type="pmid">32203189</pub-id></mixed-citation></ref><ref id="CIT0039"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ullrich</surname><given-names>S.</given-names></name>, &#x00026; <name name-style="western"><surname>Nitsche</surname><given-names>C.</given-names></name></person-group> (<year>2020</year>). <article-title>The SARS-CoV-2 main protease as drug target</article-title>. <source><italic toggle="yes">Bioorganic &#x00026; Medicinal Chemistry Letters</italic></source>, (<issue>17</issue>), <fpage>127377</fpage>
<pub-id pub-id-type="doi">10.1016/j.bmcl.2020.127377</pub-id><pub-id pub-id-type="pmid">32738988</pub-id></mixed-citation></ref><ref id="CIT0040"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Greene</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Qi</surname><given-names>R.</given-names></name>, &#x00026; <name name-style="western"><surname>Luo</surname><given-names>R.</given-names></name></person-group> (<year>2018</year>). <article-title>Recent developments and applications of the MMPBSA method</article-title>. <source><italic toggle="yes">Frontiers in Molecular Biosciences</italic></source>, , <fpage>87</fpage>
<pub-id pub-id-type="doi">10.3389/fmolb.2017.00087</pub-id></mixed-citation></ref><ref id="CIT0041"><mixed-citation publication-type="newspaper"><person-group person-group-type="author"><collab>World Health Organization.</collab></person-group> (<year>2020</year>). <italic>Coronavirus (COVID-19) events as they happen</italic>. Who.</mixed-citation></ref><ref id="CIT0042"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Zhong</surname><given-names>W.</given-names></name>, &#x00026; <name name-style="western"><surname>Hao</surname><given-names>P.</given-names></name></person-group> (<year>2020</year>). <article-title>Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission</article-title>. <source><italic toggle="yes">Science China Life Sciences</italic></source>, (<issue>3</issue>), <fpage>457</fpage>&#x02013;<lpage>460</lpage>. <pub-id pub-id-type="doi">10.1007/s11427-020-1637-5</pub-id><pub-id pub-id-type="pmid">32009228</pub-id></mixed-citation></ref><ref id="CIT0043"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yin</surname><given-names>Y.</given-names></name>, &#x00026; <name name-style="western"><surname>Wunderink</surname><given-names>R. G.</given-names></name></person-group> (<year>2018</year>). <article-title>MERS, SARS and other coronaviruses as causes of pneumonia</article-title>. <source>Respirology (Carlton, V<italic toggle="yes">ic.)</italic></source>, (<issue>2</issue>), <fpage>130</fpage>&#x02013;<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1111/resp.13196</pub-id></mixed-citation></ref><ref id="CIT0044"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Saravanan</surname><given-names>K. M.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name>, &#x00026; <name name-style="western"><surname>Hossain</surname><given-names>T.</given-names></name></person-group> (<year>2020</year>). <article-title>Deep learning based drug screening for novel coronavirus 2019-nCov</article-title>. <source><italic toggle="yes">Interdiscip Sci</italic></source>, <italic>Jun 1</italic>, 1&#x02013;9. <ext-link ext-link-type="uri" xlink:href="10.1007/s12539-020-00376-6">10.1007/s12539-020-00376-6</ext-link></mixed-citation></ref><ref id="CIT0045"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Curth</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Drosten</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Sauerhering</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Becker</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Rox</surname><given-names>K.</given-names></name>, &#x00026; <name name-style="western"><surname>Hilgenfeld</surname><given-names>R.</given-names></name></person-group> (<year>2020</year>). <article-title>Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved &#x003b1;-ketoamide inhibitors</article-title>. <source><italic toggle="yes">Science (New York, N.Y.)</italic></source>, (<issue>6489</issue>), <fpage>409</fpage>&#x02013;<lpage>412</lpage>. <pub-id pub-id-type="doi">10.1126/science.abb3405</pub-id></mixed-citation></ref><ref id="CIT0046"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>Q.</given-names></name>, &#x00026; <name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name></person-group> (<year>2020</year>). <article-title>Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak</article-title>. <source><italic toggle="yes">Current Biology</italic></source>, (<issue>7</issue>), <fpage>1346</fpage>&#x02013;<lpage>1351.e2</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2020.03.022</pub-id><pub-id pub-id-type="pmid">32197085</pub-id></mixed-citation></ref><ref id="CIT0047"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Yuan</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Liao</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Su</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Yuan</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Qian</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Hong</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>He</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>He</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Ge</surname><given-names>S.</given-names></name>, &#x02026; <name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name></person-group> (<year>2020</year>). <article-title>Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019</article-title>.&#x000a0;<italic>Clinical Infectious Diseases</italic>
<ext-link ext-link-type="uri" xlink:href="10.1093/cid/ciaa344">10.1093/cid/ciaa344</ext-link></mixed-citation></ref></ref-list></back></article>